Skip to main content
Top
Published in: BMC Infectious Diseases 1/2015

Open Access 01-12-2015 | Research article

Surveillance for severe acute respiratory infections (SARI) in hospitals in the WHO European region - an exploratory analysis of risk factors for a severe outcome in influenza-positive SARI cases

Authors: Tamara J Meerhoff, Artan Simaku, Dritan Ulqinaku, Liana Torosyan, Natalia Gribkova, Veronica Shimanovich, Giorgi Chakhunashvili, Irakli Karseladze, Aizhan Yesmagambetova, Ainagul Kuatbayeva, Zuridin Nurmatov, Dinagul Otorbaeva, Emilia Lupulescu, Odette Popovici, Elizaveta Smorodintseva, Anna Sominina, Olga Holubka, Olga Onyshchenko, Caroline S Brown, Diane Gross

Published in: BMC Infectious Diseases | Issue 1/2015

Login to get access

Abstract

Background

The 2009 H1N1 pandemic highlighted the need to routinely monitor severe influenza, which lead to the establishment of sentinel hospital-based surveillance of severe acute respiratory infections (SARI) in several countries in Europe. The objective of this study is to describe characteristics of SARI patients and to explore risk factors for a severe outcome in influenza-positive SARI patients.

Methods

Data on hospitalised patients meeting a syndromic SARI case definition between 2009 and 2012 from nine countries in Eastern Europe (Albania, Armenia, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Romania, Russian Federation and Ukraine) were included in this study. An exploratory analysis was performed to assess the association between risk factors and a severe (ICU, fatal) outcome in influenza-positive SARI patients using a multivariate logistic regression analysis.

Results

Nine countries reported a total of 13,275 SARI patients. The majority of SARI patients reported in these countries were young children. A total of 12,673 SARI cases (95%) were tested for influenza virus and 3377 (27%) were laboratory confirmed. The majority of tested SARI cases were from Georgia, the Russian Federation and Ukraine and the least were from Kyrgyzstan. The proportion positive varied by country, season and age group, with a tendency to a higher proportion positive in the 15+ yrs age group in six of the countries. ICU admission and fatal outcome were most often recorded for influenza-positive SARI cases aged >15 yrs. An exploratory analysis using pooled data from influenza-positive SARI cases in three countries showed that age > 15 yrs, having lung, heart, kidney or liver disease, and being pregnant were independently associated with a fatal outcome.

Conclusions

Countries in Eastern Europe have been able to collect data through routine monitoring of severe influenza and results on risk factors for a severe outcome in influenza-positive SARI cases have identified several risk groups. This is especially relevant in the light of an overall low vaccination uptake and antiviral use in Eastern Europe, since information on risk factors will help in targeting and prioritising vulnerable populations.
Appendix
Available only for authorised users
Literature
2.
go back to reference Lemaitre M, Carrat F: Comparative age distribution of influenza morbidity and mortality during seasonal influenza epidemics and the 2009 H1N1 pandemic.BMC Infect Dis 2010, 10:162.CrossRefPubMedPubMedCentral Lemaitre M, Carrat F: Comparative age distribution of influenza morbidity and mortality during seasonal influenza epidemics and the 2009 H1N1 pandemic.BMC Infect Dis 2010, 10:162.CrossRefPubMedPubMedCentral
3.
go back to reference To KK, Wong SS, Li IW, Hung IF, Tse H, Woo PC, Chan KH, Yuen KY: Concurrent comparison of epidemiology, clinical presentation and outcome between adult patients suffering from the pandemic influenza A (H1N1) 2009 virus and the seasonal influenza A virus infection.Postgrad Med J 2010, 86(1019:515–521.CrossRefPubMed To KK, Wong SS, Li IW, Hung IF, Tse H, Woo PC, Chan KH, Yuen KY: Concurrent comparison of epidemiology, clinical presentation and outcome between adult patients suffering from the pandemic influenza A (H1N1) 2009 virus and the seasonal influenza A virus infection.Postgrad Med J 2010, 86(1019:515–521.CrossRefPubMed
4.
go back to reference Gilca R, De Serres G, Boulianne N, Ouhoummane N, Papenburg J, Douville-Fradet M, Fortin E, Dionne M, Boivin G, Skowronski DM: Risk factors for hospitalization and severe outcomes of 2009 pandemic H1N1 influenza in Quebec, Canada.Influenza Other Respi Viruses 2011, 5(4:247–255.CrossRef Gilca R, De Serres G, Boulianne N, Ouhoummane N, Papenburg J, Douville-Fradet M, Fortin E, Dionne M, Boivin G, Skowronski DM: Risk factors for hospitalization and severe outcomes of 2009 pandemic H1N1 influenza in Quebec, Canada.Influenza Other Respi Viruses 2011, 5(4:247–255.CrossRef
5.
go back to reference Mytton OT, Rutter PD, Mak M, Stanton EA, Sachedina N, Donaldson LJ: Mortality due to pandemic (H1N1) 2009 influenza in England: a comparison of the first and second waves.Epidemiol Infect 2012, 140(9:1533–1541.CrossRefPubMed Mytton OT, Rutter PD, Mak M, Stanton EA, Sachedina N, Donaldson LJ: Mortality due to pandemic (H1N1) 2009 influenza in England: a comparison of the first and second waves.Epidemiol Infect 2012, 140(9:1533–1541.CrossRefPubMed
7.
go back to reference Van Kerkhove MD, Vandemaele KA, Shinde V, Jaramillo-Gutierrez G, Koukounari A, Donnelly CA, Carlino LO, Owen R, Paterson B, Pelletier L, Vachon J, Gonzalez C, Hongjie Y, Zijian F, Chuang SK, Au A, Buda S, Krause G, Haas W, Bonmarin I, Taniguichi K, Nakajima K, Shobayashi T, Takayama Y, Sunagawa T, Heraud JM, Orelle A, Palacios E, van der Sande MA, Wielders CC, et al: Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis.PLoS Med 2011, 8(7):e1001053.CrossRefPubMedPubMedCentral Van Kerkhove MD, Vandemaele KA, Shinde V, Jaramillo-Gutierrez G, Koukounari A, Donnelly CA, Carlino LO, Owen R, Paterson B, Pelletier L, Vachon J, Gonzalez C, Hongjie Y, Zijian F, Chuang SK, Au A, Buda S, Krause G, Haas W, Bonmarin I, Taniguichi K, Nakajima K, Shobayashi T, Takayama Y, Sunagawa T, Heraud JM, Orelle A, Palacios E, van der Sande MA, Wielders CC, et al: Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis.PLoS Med 2011, 8(7):e1001053.CrossRefPubMedPubMedCentral
8.
go back to reference WHO: Vaccines against influenza WHO position paper - November 2012. Wkly Epidemiol Rec 2012, 47(87):461–476. WHO: Vaccines against influenza WHO position paper - November 2012. Wkly Epidemiol Rec 2012, 47(87):461–476.
9.
go back to reference Zolotusca L, Jorgensen P, Popovici O, Pistol A, Popovici F, Widdowson MA, Alexandrescu V, Ivanciuc A, Cheng PY, Gross D, Brown CS, Mott JA: Risk factors associated with fatal influenza, Romania, October 2009-May 2011.Influenza Other Respi Viruses 2014, 8(1):8–12.CrossRef Zolotusca L, Jorgensen P, Popovici O, Pistol A, Popovici F, Widdowson MA, Alexandrescu V, Ivanciuc A, Cheng PY, Gross D, Brown CS, Mott JA: Risk factors associated with fatal influenza, Romania, October 2009-May 2011.Influenza Other Respi Viruses 2014, 8(1):8–12.CrossRef
10.
go back to reference Jorgensen P, Wasley A, Mereckiene J, Cotter S, Weber JT, Brown CS: Unequal access to vaccines in the WHO European Region during the A(H1N1) influenza pandemic in 2009.Vaccine 2013, 31(38):4060–4062.CrossRefPubMed Jorgensen P, Wasley A, Mereckiene J, Cotter S, Weber JT, Brown CS: Unequal access to vaccines in the WHO European Region during the A(H1N1) influenza pandemic in 2009.Vaccine 2013, 31(38):4060–4062.CrossRefPubMed
11.
go back to reference Palache A: Seasonal influenza vaccine provision in 157 countries (2004–2009) and the potential influence of national public health policies.Vaccine 2011, 29(51):9459–9466.CrossRefPubMed Palache A: Seasonal influenza vaccine provision in 157 countries (2004–2009) and the potential influence of national public health policies.Vaccine 2011, 29(51):9459–9466.CrossRefPubMed
15.
go back to reference Snacken R, Quinten C, Devaux I, Plata F, Broberg E, Zucs P, Amato-Gauci A: Surveillance of hospitalised severe cases of influenza A(H1N1)pdm09 and related fatalities in nine EU countries in 2010–2011.Influenza Other Respi Viruses 2012, 6(6):e93–96.CrossRef Snacken R, Quinten C, Devaux I, Plata F, Broberg E, Zucs P, Amato-Gauci A: Surveillance of hospitalised severe cases of influenza A(H1N1)pdm09 and related fatalities in nine EU countries in 2010–2011.Influenza Other Respi Viruses 2012, 6(6):e93–96.CrossRef
16.
go back to reference Bagdure D, Curtis DJ, Dobyns E, Glode MP, Dominguez SR: Hospitalized children with 2009 pandemic influenza A (H1N1): comparison to seasonal influenza and risk factors for admission to the ICU.PloS one 2010, 5(12):e15173.CrossRefPubMedPubMedCentral Bagdure D, Curtis DJ, Dobyns E, Glode MP, Dominguez SR: Hospitalized children with 2009 pandemic influenza A (H1N1): comparison to seasonal influenza and risk factors for admission to the ICU.PloS one 2010, 5(12):e15173.CrossRefPubMedPubMedCentral
17.
go back to reference Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, Vugia D, Harriman K, Matyas B, Glaser CA, Samuel MC, Rosenberg J, Talarico J, Hatch D; California, Pandemic (H1N1) Working Group: Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California.JAMA 2009, 302(17):1896–1902.CrossRefPubMed Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, Vugia D, Harriman K, Matyas B, Glaser CA, Samuel MC, Rosenberg J, Talarico J, Hatch D; California, Pandemic (H1N1) Working Group: Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California.JAMA 2009, 302(17):1896–1902.CrossRefPubMed
18.
go back to reference Cardeñosa N, Rodés A, Follia N, Plasencia E, Lafuente S, Arias C, Torra R, Minguell S, Ferrús G, Barrabeig I, Godoy P: Epidemiological analysis of severe hospitalized 2009 pandemic influenza A (H1N1) cases in Catalonia, Spain.Human vaccines 2011, 7(Suppl):226–229.CrossRefPubMed Cardeñosa N, Rodés A, Follia N, Plasencia E, Lafuente S, Arias C, Torra R, Minguell S, Ferrús G, Barrabeig I, Godoy P: Epidemiological analysis of severe hospitalized 2009 pandemic influenza A (H1N1) cases in Catalonia, Spain.Human vaccines 2011, 7(Suppl):226–229.CrossRefPubMed
19.
go back to reference Mertz D, Kim TH, Johnstone J, Lam PP, Science M, Kuster SP, Fadel SA, Tran D, Fernandez E, Bhatnagar N, Loeb M: Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. Bmj-Brit Med J 2013, 347:f5061. Mertz D, Kim TH, Johnstone J, Lam PP, Science M, Kuster SP, Fadel SA, Tran D, Fernandez E, Bhatnagar N, Loeb M: Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. Bmj-Brit Med J 2013, 347:f5061.
20.
go back to reference Balabanova D, McKee M, Pomerleau J, Rose R, Haerpfer C: Health service utilization in the former soviet union: evidence from eight countries.Health Serv Res 2004, 39(6 Pt 2):1927–1950.CrossRefPubMedPubMedCentral Balabanova D, McKee M, Pomerleau J, Rose R, Haerpfer C: Health service utilization in the former soviet union: evidence from eight countries.Health Serv Res 2004, 39(6 Pt 2):1927–1950.CrossRefPubMedPubMedCentral
Metadata
Title
Surveillance for severe acute respiratory infections (SARI) in hospitals in the WHO European region - an exploratory analysis of risk factors for a severe outcome in influenza-positive SARI cases
Authors
Tamara J Meerhoff
Artan Simaku
Dritan Ulqinaku
Liana Torosyan
Natalia Gribkova
Veronica Shimanovich
Giorgi Chakhunashvili
Irakli Karseladze
Aizhan Yesmagambetova
Ainagul Kuatbayeva
Zuridin Nurmatov
Dinagul Otorbaeva
Emilia Lupulescu
Odette Popovici
Elizaveta Smorodintseva
Anna Sominina
Olga Holubka
Olga Onyshchenko
Caroline S Brown
Diane Gross
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2015
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-014-0722-x

Other articles of this Issue 1/2015

BMC Infectious Diseases 1/2015 Go to the issue